Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
2 Nov 2026
IL-33 Inhibition Reduces COPD Exacerbations in Phase III Trials
Two Phase III trials involving 1,750 COPD patients found that IL-33 inhibition reduced moderate-to-severe exacerbation rates by 29–34% over 52 weeks.
2 Nov 2026
Vagus Nerve Stimulation Therapy™ in Drug-Resistant Epilepsy
Navigate a case study of a patient with drug-resistant epilepsy, exploring presentation, refractory symptoms, and conversations…
6
Mins
2 Nov 2026
Regulatory Science: A Condition of Innovation for AI as a Medical Device
The existing framework is built for stable, predictable products with well-established pre-market risk clarity…
1 Nov 2026
CRISPR Screens Reveal New Genes Regulating Red Blood Cell Density
CRISPR screens identified 17 genes and 13 genomic regions linked to red blood cell density, providing new insights into how genetic variants influence red blood cell traits.
1 Nov 2026
Skin Bacterial Cluster Linked to Lower Childhood Allergy
Gut-associated bacterial DNA on eczema-free skin was linked to lower later sensitisation and allergic rhinitis rates.
1 Nov 2026
Respiratory Muscle Weakness Linked to Sleep Apnoea Severity
A multicentre study linked greater hypoxic burden to increased systemic inflammation and reduced respiratory muscle strength in patients with obstructive sleep apnoea.
1 Nov 2026
Gut Microbiome Signatures Predict Cardiac Remodelling
Gut microbiome signatures predicted adverse and reverse cardiac remodelling in preclinical heart failure, with machine learning models demonstrating promising accuracy and consistent performance in an independent cohort.
1 Nov 2026
Targeted ADC Delays Progression in Relapsed Osteosarcoma: ESMO 2026
Risvutatug rezetecan ADC treatment extended progression-free survival in relapsed osteosarcoma, but serious toxicity was frequent.
1 Nov 2026
Physical Activity Linked to Lower Cardiovascular Mortality in MASLD
A study found that higher moderate-to-vigorous physical activity was associated with lower cardiovascular and all-cause mortality among individuals with metabolic dysfunction-associated steatotic liver disease.
1 Nov 2026
Ultrasound-Guided Drainage Treats Deep Neck Abscesses
A multicentre study found that ultrasound-guided catheter drainage successfully treated 84.5% of patients with deep neck space abscesses. Serious associated events independently predicted treatment failure.
←
1
2
3
4
5
6
…
1,644
1,645
1,646
→
We’ve noticed you’re accessing
from
North/South America.
View
View